<div id="readability-page-1"><div><p>ALI HEALTH (00241.HK)<span> </span><span> -0.200 (-4.405%)  </span> <span> Short selling $332.54M; Ratio 37.462%  </span>  opened 0.22% lower this morning (15th) and once hit a trough of HKD4.25. It last quoted at HKD4.35, down 4.19%, with turnover of 121 million shares, involving HKD530 million.</p><p>After market close yesterday (14th), ALI HEALTH announced its full-year results for the year ended March 2026. Revenue added 12% YoY to RMB34.255 billion. Net profit increased 35.2% YoY to RMB1.936 billion, with EPS of RMB12.02 cents. Total dividend amounted to RMB19.47 cents per share, including a final dividend of RMB5.95 cents and a special dividend of RMB13.52 cents. Adjusted net profit was RMB2.326 billion, up 19.3% YoY. </p><p>Citi said in a report that ALI HEALTH's full-year results were largely in line. The first-time declaration of a special dividend demonstrates strong confidence in its cash generation capability and capital return. Citi set a TP of HKD9 and rated the stock Buy/ High Risk.</p><p>BofA Securities said in a research report that ALI HEALTH's FY26 results were within guidance but slightly below market expectations, implying slower growth in the second half of the fiscal year. Nevertheless, the special dividend came as a positive surprise. The broker was encouraged by the company's enhanced shareholder returns, maintaining its Buy rating with a TP of HKD6.<br/>(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)</p></div></div>

00241

<p>ALI HEALTHshares fell over 4% following the announcement of its full-year results, which showed a 12% revenue increase to RMB34.255 billion and a 35.2% rise in net profit to RMB1.936 billion. Citi noted the results were in line with expectations, while BofA highlighted a positive surprise from a special dividend. Citi set a target price of HKD9, while BofA maintained a target of HKD6.</p>

AASTOCKS News

ALI HEALTH

Citigroup

Bank of America

CITIGROUP INC 6.250 NON CUM SER II PFD WI

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

ALI HEALTH Dives 4%+ as Citi Says Results In Line; BofAS Notes Surprise from Spec. Div.